Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are drugs designed to lower plasma glucose concentration by inhibiting Na -glucose-coupled transport in the proximal tubule. Clinical trials demonstrate these drugs have favorable effects on cardiovascular outcomes to include slowing the progression...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical journal of the American Society of Nephrology Jg. 16; H. 8; S. 1284
Hauptverfasser:	Palmer, Biff F, Clegg, Deborah J
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.08.2021
Schlagworte:	Blood Glucose - metabolism Humans Ketosis - blood Ketosis - chemically induced Ketosis - physiopathology Ketosis - therapy Kidney - drug effects Kidney - physiopathology Risk Factors Sodium-Glucose Transporter 2 Inhibitors - adverse effects euglycemic ketoacidosis sodium glucose co-transporter inhibitor
ISSN:	1555-905X, 1555-905X
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!